Clinical Trial Update: Fruquintinib Plus Capecitabine Versus Bevacizumab Plus Capecitabine as Maintenance Therapy Following First-line Treatment for Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Fruquintinib plus capecitabine versus Bevacizumab plus capecitabine as maintenance therapy after first-line treatment in metastatic colo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• Fruquintinib (fruquintinib)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN